The Friedman Brain Institute offers one of the most comprehensive multiple sclerosis (MS) treatment programs in the United States.
Our broad base of physicians, scientists, and other medical specialists offer cutting-edge programs in disease management, including diagnostics and experimental therapeutics, as well as mental health care and support services. Working under the auspices of The Friedman Brain Institute, the Corinne Goldsmith Dickinson Center for Multiple Sclerosis, led by Director Fred D. Lublin, MD, is dedicated to improving the quality of life for patients with MS and finding a cure for this potentially debilitating autoimmune disease.
Treatments at Mount Sinai Health System
We offer comprehensive, centralized care, including:
- Disease management
- Support services
Through research, we are developing novel and more effective therapies and gaining new levels of insight into the nature of MS. Under the direction of internationally acclaimed neuroscientists, including Patrizia Casaccia, MD, PhD, we have developed pioneering clinical research and basic science programs. Our researchers use state-of-the-art technologies to gain a better understanding of the progressive phase of the disease and to identify new treatments aimed at restoring function. Our research includes:
- Participation in clinical research protocols of novel therapeutics.
- A focus on the myelin sheath and glial-cell biology, in addition to myelin repair, regeneration, and neuroprotection.
- Efforts to develop new diagnostic tests, such as through neuroimaging.
We support a leading clinical trials program and recruit patients for a wide range of clinical trials testing the effectiveness of new treatments. These clinical trials provide eligible patients with access to therapies not yet widely available.
Our doctors and scientists were among the first in the country to:
- Spearhead studies of Interferon beta-1b
- Pilot a clinical trial of a potential new therapy for neuromyelitis optica
The Friedman Brain Institute provides a multidisciplinary approach to the care and treatment of patients with MS, conducts advanced scientific research on the disease, and administers innovative clinical trials, with the vision of creating a holistic approach to treating each patient.